| Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Hepatology | 2006 | 2.3K |
| Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer | New England Journal of Medicine | 2019 | 960 |
| Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis | Critical Care Medicine | 2003 | 623 |
| Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057) | Journal of Clinical Oncology | 2017 | 495 |
| Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry | Circulation | 2008 | 469 |
| European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators | Resuscitation | 2010 | 434 |
| Melatonin: buffering the immune system | International Journal of Molecular Sciences | 2013 | 399 |
| Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study | Gastroenterology | 2018 | 308 |
| Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) | Annals of Oncology | 2010 | 270 |
| Severe community-acquired pneumonia. Etiology, prognosis, and treatment | The American Review of Respiratory Disease | 1990 | 269 |
| Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial | Lancet Oncology, The | 2017 | 259 |
| Survival in pulmonary hypertension in Spain: insights from the Spanish registry | European Respiratory Journal | 2012 | 258 |
| Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer | Journal of Clinical Oncology | 2012 | 214 |
| Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation | Journal of the American College of Cardiology | 2014 | 207 |
| Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases | Medicine (United States) | 2011 | 203 |
| PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers | BMC Medical Genomics | 2012 | 199 |
| Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome | American Journal of Respiratory and Critical Care Medicine | 2001 | 197 |
| Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial | JAMA Oncology | 2015 | 193 |
| Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) | Circulation | 2017 | 182 |
| Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer | Nature Communications | 2018 | 182 |
| Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts | Autoimmunity Reviews | 2012 | 176 |
| Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up | Journal of the American College of Cardiology | 2016 | 168 |
| N-3 fatty acids, cancer and cachexia: a systematic review of the literature | British Journal of Nutrition | 2007 | 165 |
| Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Critical Care | 2005 | 162 |
| Pneumocystis jirovecii in general population | Emerging Infectious Diseases | 2005 | 150 |
